HER3 expression or overexpression has been described in multiple epithelial tumors, including breast, ovarian, lung, colon, pancreatic, melanoma, gastric, head and neck, and even prostate cancers (15, 33–36). Here, ERBB3 is linked to Familial prostate cancer.